Navigation Links
Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
Date:11/7/2012

177542Total assets 

$  110,134$  149,700Liabilities and stockholders' equity Current liabilities:Accounts payable and accrued expenses 

$   17,775$
4,277Deferred revenue, current portion 

3,4293,429Total current liabilities 

21,2047,706Deferred revenue, less current portion 

39,42942,000Other long-term liabilities 

140288Commitments and contingenciesStockholders' equity:Preferred stock, $.001 par value, 10,000,000 shares authorized at September 30, 2012 and December 31, 2011; noshares issued and outstanding atat September 30, 2012 and December 31, 2011--Common stock, $.001 par value, 300,000,000 sharesauthorized at September 30, 2012 and December 31, 2011;70,727,827 and 61,285,514 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively

7161Additional paid-in capital 

453,624446,357Accumulated other comprehensive income (loss)

15(2)Accumulated deficit

(404,349)(346,710)Total stockholders' equity 

49,36199,706Total liabilities and stockholders' equity 

$  110,134$  149,700 Orexigen Therapeutics, Inc.Statements of Operations(In thousands, except per share amounts)(Unaudited)Three Months Ended Nine Months Ended September 30, September 30, 2012201120122011Revenues:Collaborative agreement 

$
857$
857$
2,571$
2,571License revenue ---971Total revenues 

8578572,5713,542Operating expenses:Research and development 

25,8061,53945,42811,237General and administrative 

5,6513,90714,90515,870Total operating expenses 

31,4575,44660,33327,107Loss from operations 

(30,600)(4,589)(57,762)(23,565)Other income (expense):Interest income 

36912535Interest expense 

--(2)(221)Total other income (expense) <
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
2. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
4. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
5. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
8. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
9. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
10. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
11. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... DUBLIN , Apr. 24, 2015 /PRNewswire/ ... ) has announced the addition of the ... Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & ... Institute) - Global Forecast to 2020" ... global laboratory accessories market is expected to ...
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
(Date:4/23/2015)... 24, 2015  AbbVie (NYSE: ABBV ) has ... has accepted its New Drug Application (NDA) and granted ... antiviral treatment of ombitasvir, paritaprevir, ritonavir (OBV/PTV/r), with ribavirin ... with chronic genotype 4 (GT4) hepatitis C virus (HCV) ... interferon-free therapy being evaluated by the FDA for patients ...
Breaking Medicine Technology:Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Lannett Expands Revolving Credit Facility To $120 Million 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 2U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 3U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 4U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 5U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 6U.S. FDA Grants Priority Review to AbbVie for Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Genotype 4 Chronic Hepatitis C 7
... Nov. 22, 2011 Cadence Pharmaceuticals, Inc. (Nasdaq: ... previously announced public offering of 21,800,000 shares of its ... full exercise of an over-allotment option previously granted to ... per share.  The net proceeds from the offering, after ...
... Nov. 22, 2011  Medical Science Liaisons are the ... in the marketplace. Biopharmaceutical and medical device companies ... services to a diverse set of customers that ... opinion leaders, payer and government thought leaders, and ...
Cached Medicine Technology:Cadence Pharmaceuticals Announces Completion of Public Offering of Common Stock, Including Full Exercise of Over-Allotment Option by Underwriters 2Delivering Exceptional Medical Science Liaison Services to Key Stakeholders in the Marketplace 2
(Date:4/26/2015)... Viejo, CA (PRWEB) April 26, 2015 With ... Final Cut Pro X editors can quickly and easily ... Lookup Table that contains a mathematical formula for modifying an ... color indicated by the table. This pack comes with 60 ... inspired by vintage and contemporary black and white films. ...
(Date:4/26/2015)... 2015 A live auction will be ... from hospitals, surgery centers and other medical facilities around ... sold including radiology, surgery, endoscopy, lab, anesthesia, exam and ... place Tuesday, April 28th starting at 10:00am EDT. The ... 5025 North Hiatus Rd., Sunrise, FL 33351. Anyone ...
(Date:4/26/2015)... York (PRWEB) April 26, 2015 This ... events of the season and will include a spectacular ... purses, totes, collectibles, herbal soaps and incense, chimes, vases, ... browsing this year’s exciting and unique collection of vendors, ... afternoon with Jim Martocci and the Jimmie Jazz Band. ...
(Date:4/26/2015)... 2015 Forbes Living is scheduled ... one which is synonymous with clean beaches, sparkling office buildings, ... are major economic influencers in the city on the Pacific ... show are pleased to announce the show will be broadcast ... 3:00 PM PDT. Tune in to find out what the ...
(Date:4/26/2015)... 26, 2015 MidSouth Pain Treatment ... the Southeast. MidSouth Pain Treatment Center is a comprehensive ... Southaven, Oxford and Jackson, two ambulatory surgery centers in ... Southaven and Cordova locations. , Dr. Michael Steuer ... into medicine to help people, and when I discovered ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2Health News:Centurion Service Group to Auction off 1,200 Lots of Medical Equipment 2Health News:It’s Coming! The 5th Annual Tulip Festival & Mother’s Day Celebration at Honor's Haven Resort & Spa! 2Health News:Forbes Living TV Will Air in San Diego, California 2Health News:Growing Pains for MidSouth Pain Treatment Center 2
... Brazilian researchers have performed the first-ever autopsy study to examine ... swine flu. "The lack of information on the ... better clinical management and hinders the development of a therapeutic ... of the Department of Pathology at So Paulo University, in ...
... Seek to retain federal policy on abortion funding and ... health care that immigrants have now, remove barriers to access ... coverage standards , WASHINGTON, Dec. 22 The current ... forward without "essential changes," the chairmen of three committees of ...
... , AUL Legal Team Documents Reveal Details on Mandatory Abortion Tax ... floor of the United States Senate, Senator Ben Nelson of Nebraska made ... cannot constructively point out how it doesn,t prohibit the use of federal ... just didn,t like the language..." , As a result ...
... , LOS ANGELES, Dec. 22 ... Last-minute surprises are not uncommon. For Shonna Galloway, administrator ... employer,s grand opening in October 2007 was one she,ll never forget. ... scheduling software system by the parent company of our new practice. ...
... FRC,s Tony Perkins Calls Closure the "Height of Arrogance" ... Research Council President Tony Perkins attempted to deliver a letter to ... federal security that her offices were "closed for the holidays." ... of Senator Landrieu,s office to urge the Senator to oppose the ...
... , , CHEVY CHASE, Md., Dec. 22 ... has completed the sale of 40 long-term care facilities to Omega ... the terms of the previously announced Securities Purchase Agreement between the ... Omega of $234.8 million, consisting of $184.2 million in cash; and ...
Cached Medicine News:Health News:Researchers find new patterns in H1N1 deaths 2Health News:Bishops Call Senate Health Care Reform Bill 'Deficient,' Essential Changes Needed Before Moving Forward 2Health News:Bishops Call Senate Health Care Reform Bill 'Deficient,' Essential Changes Needed Before Moving Forward 3Health News:Americans United for Life Offers Urgent Legal Briefing for Senator Nelson 2Health News:Brand-New Radiology Clinic Exceeds Every Industry Performance Standard Using MedInformatix RIS 2Health News:Brand-New Radiology Clinic Exceeds Every Industry Performance Standard Using MedInformatix RIS 3Health News:Brand-New Radiology Clinic Exceeds Every Industry Performance Standard Using MedInformatix RIS 4Health News:Senator Landrieu Closes Office: Constituents Turned Away at the Door, Callers Reach Only Busy Signals 2Health News:CapitalSource Closes First Step of Long-Term Care Facility Sale to Omega Healthcare Investors 2Health News:CapitalSource Closes First Step of Long-Term Care Facility Sale to Omega Healthcare Investors 3
... System is a single-use, disposable needle loading ... into a Bard BrachyStar needle for interstitial ... radiation safety shield, inner compartment that holds ... fitting that connects the cartridge to the ...
... Holter Monitoring System uses technology developed by ... first true 12-lead digital Holter recorder in ... beat contained in the 24-hour study provides ... work done by the Q-12 digital recorder ...
Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
... any clinical setting, offering an exclusive ... procedure. Customize Delphis™ to your exact ... Pocket PC, a Touchpad PC Tablet ... technology allows you to focus on ...
Medicine Products: